Potassium 99 mg

A clearly labeled 494 mg of potassium bicarbonate provides a meaningful, alkalizing alternative to the original's potassium contribution. The simple powder improves dose clarity, but impaired kidney function or potassium-retaining medicines can make the amount unsafe without guidance.

Potassium citrate supplies a meaningful 448 mg amount in a well-absorbed, alkalizing form. Its focused label gives stronger form and dose clarity than many mixed products, while kidney impairment and potassium-retaining medicines can raise blood potassium too far.

A named Albion amino acid complex provides a clearly identified potassium form for users who prefer a low-dose capsule. The 99 mg amount is far smaller than the higher-dose powder options, so its advantage is form clarity rather than substantial electrolyte delivery.

A clearly quantified 365 mg of potassium chloride makes this a focused, low-cost substitute for the original's potassium component. Chloride supports electrolyte replacement but lacks the buffering role of citrate or bicarbonate, and kidney impairment or potassium-retaining medicines can make supplementation unsafe.

The simple powder provides 365 mg of potassium as chloride with very low recurring cost. It is easier to assess than a broad blend but lacks citrate's buffering role, while kidney impairment or potassium-retaining medicines remain important cautions.

A 99 mg potassium amino acid complex offers a low-cost, deliberately modest alternative to the original. The amount contributes little beside daily dietary needs, so it fits limited supplementation rather than substantial electrolyte replacement.

A simple capsule supplies 200 mg of potassium citrate, providing an absorbable and alkalizing form at a moderate amount. It offers a practical middle ground between low-dose tablets and concentrated powders, with the same kidney and medication cautions that apply to added potassium.

A focused powder supplies 175 mg of potassium gluconate with excellent recurring value. The amount is more useful than a basic 99 mg tablet but remains a limited contribution beside dietary needs, and potassium retention from kidney disease or medicines still matters.

A 99 mg potassium glycinate amino acid complex offers a clearly identified chelated form in a focused capsule. The small amount limits practical electrolyte impact, so its value depends on preferring a modest dose over concentrated potassium powders.